Stock market Updates | Sanofi India Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY14371.90  -218.45 (-1.50%)
SENSEX48878.54  -746.22 (-1.50%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileSmart Quotes

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE8412.40-32.9 (-0.39 %)
PREV CLOSE (Rs.) 8445.30
OPEN PRICE (Rs.) 8443.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7089
TODAY'S LOW / HIGH (Rs.)8380.00 8524.55
52 WK LOW / HIGH (Rs.)5900.05 8999
NSE8406.15-42.75 (-0.51 %)
PREV CLOSE( Rs. ) 8448.90
OPEN PRICE (Rs.) 8450.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 8406.15 (13)
VOLUME 44877
TODAY'S LOW / HIGH(Rs.) 8369.95 8525.00
52 WK LOW / HIGH (Rs.)5900 8989

Smart Quotes

BSE NSE
1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
597.96
Dividend Yield(%)
4.15
TTM EPS (Rs.)
195.74
P/E Ratio
42.98
Book Value (Rs.)
1215.00
Face Value (Rs.)
10
MCap (Rs. in Mn)
193742.80
Price/Earning (TTM)
36.27
Price/Sales (TTM)
6.44
Price/Book (MRQ)
6.92
PAT Margin (%)
13.49
ROCE (%)
25.75
company info
Incorporation Year : 02-05 1956

Management Info :

Aditya Narayan - Chairman Rajaram Narayanan - Managing Director

Registered Office :

Address : Sanofi House, 117-b,L&t Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone :

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
News
19Jan Sanofi India informs about loss of sha
Sanofi India has informed that the Company has received communication fr..
11Dec Sanofi India informs about loss of sha
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure..
28Oct Sanofi India informs about loss of sha
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosur..
more
Financials
QTR Sep 20 ANNUAL 19
Net Profit13294142
Gross Profit 1859 5999
Operating Profit 2071 7594
Net Sales 6866 30706
more
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Gland Pharma (BSE)
Rwadiwala-peer-arrow  2282.90 (3.53%)
M.Cap (Rs. in Cr)37275.84
Solara Active Pharma (BSE)
Rwadiwala-peer-arrow  1344.25 (4.17%)
M.Cap (Rs. in Cr)4827.17
RPG Life Sciences (BSE)
Rwadiwala-peer-arrow  444.50 (6.54%)
M.Cap (Rs. in Cr)735.16
Aurobindo Pharma (BSE)
Rwadiwala-peer-arrow  923.65 (2.33%)
M.Cap (Rs. in Cr)54120.22
Shareholding Pattern
PROMOTERS
60.4%
FI/BANKS/INSURANCE
5.82%
MUTUAL FUNDS/UTI
11.59%
FII
11.54%
NON-INSTITUTION
10.62%
GOVERNMENT
0%
more
Mf Holdings
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.